adenocarcinoma

You have access
(Pro)renin Receptor Down-regulation Is Associated With a Higher Risk of Recurrence in Lung Adenocarcinoma
NACHINO KIMURA, KYUICHI KADOTA, EMI IBUKI, RYOU ISHIKAWA, TOSHIHIRO IKEDA, CHIHIRO YOSHIDA, TOSHIKI YAJIMA, AKIRA NISHIYAMA and REIJI HABA

Anticancer Research December 2023, 43 (12) 5671-5680; DOI: https://doi.org/10.21873/anticanres.16772
Open Access
Treatment Algorithm for Patients With Gastric Adenocarcinoma: Austrian Consensus on Systemic Therapy – An Update
EWALD WÖLL, ARNO AMANN, WOLFGANG EISTERER, ARMIN GERGER, BIRGIT GRÜNBERGER, HOLGER RUMPOLD, LUKAS WEISS, THOMAS WINDER, RICHARD GREIL and GERALD W. PRAGER

Anticancer Research July 2023, 43 (7) 2889-2897; DOI: https://doi.org/10.21873/anticanres.16460
You have access
Clinical and Oncological Impact of the Toll-like Receptor-3 and -4 in Esophageal and Gastro-esophageal Junction Adenocarcinoma
SPYRIDON DAVAKIS, ALKISTIS KAPELOUZOU, STRATIGOULA SAKELLARIOU, KONSTANTINOS G. KYRIAKOULIS, ADAM MYLONAKIS, STAVROS P. PAPADAKOS, MARIA MPOURA, MICHAIL VAILAS, DIMITRIOS ZIOGAS, THEODOROS LIAKAKOS and ALEXANDROS CHARALABOPOULOS

Anticancer Research July 2023, 43 (7) 3183-3191; DOI: https://doi.org/10.21873/anticanres.16492
You have access
Metastatic Adenocarcinoma of the Lung Presenting as a Presternal Cutaneous Mass: Case Report and Brief Literature Review
HASNA KERROUCH, MARIE DANSET, NAOUFAL HJIRA and JEAN KANITAKIS

Anticancer Research May 2023, 43 (5) 2367-2370; DOI: https://doi.org/10.21873/anticanres.16402
You have access
Neoadjuvant Therapy for Patients With Non-small Cell Lung Cancer Complicated With Chest Wall Invasion
KEIYU SATO, SHOTA NAKAMURA, YUKA KADOMATSU, HARUSHI UENO, TAKETO KATO, NAOKI OZEKI, KOICHI FUKUMOTO and TOYOFUMI FENGSHI CHEN-YOSHIKAWA

Anticancer Research November 2022, 42 (11) 5539-5546; DOI: https://doi.org/10.21873/anticanres.16059
Open Access
Comparison of Proportion of Elevated Carcinoembryonic Antigen Levels in Patients With Appendiceal and Colorectal Adenocarcinoma: A Systematic Review and Meta-analysis
ADAM T. CRISTAUDO, SCOTT B. JENNINGS and DAVID L. MORRIS

Anticancer Research September 2022, 42 (9) 4217-4235; DOI: https://doi.org/10.21873/anticanres.15922
Open Access
The Role of Toll-like Receptors in Esophageal Cancer
SPYRIDON DAVAKIS, ALKISTIS KAPELOUZOU, THEODOROS LIAKAKOS, MARIA MPOURA, DIMITRIOS STERGIOU, STRATIGOULA SAKELLARIOU and ALEXANDROS CHARALABOPOULOS

Anticancer Research June 2022, 42 (6) 2813-2818; DOI: https://doi.org/10.21873/anticanres.15762
You have access
Annexin A10 Expression as a Novel Prognostic Marker in Lung Adenocarcinoma
MASAKO YUMURA, TATSUYA NAGANO, NAOE JIMBO, RYOTA DOKUNI, TATSUNORI KIRIU, YUGO TANAKA, MOTOKO TACHIHARA, TOMOO ITOH, YOSHIMASA MANIWA, YOSHIHIRO NISHIMURA and KAZUYUKI KOBAYASHI

Anticancer Research March 2022, 42 (3) 1289-1294; DOI: https://doi.org/10.21873/anticanres.15595
You have access
Prognostic and Clinicopathological Significance of Lymph Node Metastasis in the Esophagogastric Junction Adenocarcinoma
NAOKI URAKAWA, SHINGO KANAJI, SATOSHI SUZUKI, RYUICHIRO SAWADA, HITOSHI HARADA, HIRONOBU GOTO, HIROSHI HASEGAWA, KIMIHIRO YAMASHITA, TAKERU MATSUDA, TARO OSHIKIRI and YOSHIHIRO KAKEJI

Anticancer Research February 2022, 42 (2) 1051-1057; DOI: https://doi.org/10.21873/anticanres.15566
You have access
Bilateral Lung Transplant for Treatment of Idiopathic Pulmonary Fibrosis With Undetected Lung Adenocarcinoma: A Case Report
UZAIR M. JOGIAT, QUINCY S. CHU, JAYAN NAGENDRAN, BRYCE LAING, ALIM HIRJI and BENJAMIN A. ADAM

Anticancer Research February 2022, 42 (2) 1157-1160; DOI: https://doi.org/10.21873/anticanres.15580

Main menu

User menu

Search

adenocarcinoma

Pages